Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance

Pancreatology

Volumn 5, Issue 2-3, 2005, Pages 229-233

  Chari, Suresh T ^a   Zapiach, Mauricio ^a   Yadav, Dhiraj ^a   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diabetes; Homeostasis model assessment; Insulin resistance; Pancreatic cancer; Cell function

Indexed keywords

ADULT; AGED; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 19944404452     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000085276     Document Type: Article

References (24)

1. Permert J, Larsson J, Ihse I, Pour PM: Diagnosis of pancreatic cancer. Alteration of glucose metabolism. Int J Pancreatol 1991;9:113-117.
2. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, et al: Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993;159:101-107.
3. Cersosimo E, Pisters PW, Pesola G, McDermott K, Bajorunas D: Insulin secretion and action in patients with pancreatic cancer. Cancer 1991;67:486-493.
4. Permert J, Larsson J, Westermark GT, Herrington MK, Christmanson L, et al: Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 1994;330:313-318.
5. Chari S, Klee GG, Miller LJ, Raimondo M, DiMagno EP: Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 2001;121:640-645.
6. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J: Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 1993;80:1047-1050.
7. Permert J, Adrian TE, Jacobson P, Jorfelt L, Fruin AB: Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 1993;165:61-66.
8. Basso D, Plebani M, Fogar P, Del Favero G, Briani G, et al: Beta-cell function in pancreatic adenocarcinoma. Pancreas 1994;9:332-335.
9. Permert J, Larsson J, Fruin AB, Tatemoto K, Herrington MK: Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997;15:60-68.
10. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
11. Hermans MP, Levy JC, Morris RJ, et al: Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999;42:678-687.
12. Hermans MP, Levy JC, Morris RJ, et al: Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 1999;48:1779-1786.
13. Avignon A, Boegner C, Mariano-Goulart D, et al: Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord 1999;23:512-517.
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
15. Argiles J, Lopez-Soriano FJ: Insulin and cancer (review). Int J Oncol 2001;18:683-687.
16. Yoshikawa T, Noguchi Y, Doi C, Makino T, Nomura K: Insulin resistance in patients with cancer: Relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition 2001;17:590-593.
17. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087-1092.
18. World Health Organization Expert Committee: Diabetes Mellitus. Technical Report Series. Geneva, Switzerland, 1985, p 741.
19. Jonas JC, Sharma A, Hasenkamp W, et al: Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 1999;274:14112-14121.
20. Weir GC, Laybutt DR, Kaneto H, et al: Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001;50 (suppl 1):S154-S159.
21. Fearon KC, Barber MD, Falconer JS, et al: Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 1999;23:584-588.
22. Argiles J, Lopez-Soriano JM: Cancer cachexia: A key role for TNF? Int J Oncol 1997;10:565-572.
23. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes 1994;43:1271-1278.
24. Hotamisligil GS: The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999;245:621-625.